Refine by
Immune Based Articles & Analysis: This-Year
1 articles found
The therapy uses targeted lipid nanoparticles (tLNPs) to deliver CAR-encoding mRNA directly to immune cells. This announcement marked one of the first clinical applications of in vivo CAR-T technology. ...
